Ankylosing spondylitis

AS in the news Week 9

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a  randomized, prospective, long-term, follow-up study

Good news for those of you taking Enbrel. Would be interested to hear from you on how many years you have been taking it and how you are feeling since starting it.

Background: The aim of this study was to evaluate the proportion of patients with ankylosing spondylitis maintaining clinical remission after reduction of their subcutaneous etanercept dose to 50 mg every other week compared with that in patients receiving etanercept 50 mg weekly.  Conclusion: Remission of ankylosing spondylitis is possible in at least 50% of patients treated with etanercept 50 mg weekly. After halving of the etanercept dose, remission is maintained in a high percentage of patients during long-term follow-up, with important economic implications.

     Greg’s ready for marathon challenge

I love it when fellow ASers families get involved, this is a great story. Good luck to you Greg… By the way I know of another marathoner who is making her name in the running world, Angie, who is raising money for her sister TiffeeG who is learning to live with this disease. Check out her blog, which is full of humor and beautiful pictures here.

Renowned sports artist lives quiet life in Ocala

I have marveled over this artist for decades and now to find out he is just like me!

This isn’t no laughing matter

I have talked about this before and truly believe that is makes a difference in how we view the world. I never knew Norman Cousins would laugh for 10 minutes watching a funny film in order to have two hour of painless sleep!

High Salt Diet May Trigger Autoimmune Diseases

Study released March 6 states that salt could be the trigger for autoimmune diseases. Could not be attributed to mine since I really don’t like salt!

ANRF and Walk Your AS Off Striving to Fund AS Research Grant

All the hard work is paying off, good job Jenna!

1 reply »

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s